AEM vs HUN

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

Huntsman Corporation exhibits a stable Piotroski F-Score of 5/9, but this is overshadowed by severe fundamental deterioration. The company is currently unprofitable with negative margins and a concerning 180% dividend payout ratio, indicating the dividend is unsustainable. Despite a recent 6-month price rally, the long-term trend is deeply negative, and the forward P/E of 104.07 suggests minimal expected earnings recovery. The stock is trading above the analyst target price of $12.69, leaving little room for upside given the negative growth trajectory.